Myo-inositol May Prevent Gestational Diabetes In PCOS Women
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 83 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of myo-inositol throughout pregnancy is associated with less risk of developing gestational diabetes (54% occurrence reduced to 17.2%) in women who also have PCOS. The final odds ratio was 2.4, indicating a more than double risk with placebo relative to inositol at 4,000mg daily
The Effect Of Myoinositol Supplementation On Insulin Resistance In Patients With Gestational Diabetes
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 69 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of 4,000mg inositol daily during pregnancy in otherwise healthy women significantly reduced the decline in insulin sensitivity associated with the third trimester of pregnancy.